Bristol-Myers Squibb Income Statement

Revenue, expenses, and profitability over time

Bristol-Myers Squibb generated $48.5B in trailing twelve-month revenue, up 0.0% year-over-year. Net income was $7.3B with a 15.01% net margin. Diluted EPS is $3.57, which grew 0.4% year-over-year. Based on the Q1 2026 filing.